OTC_Capitol

@TDKtoken 81M

$AMFN $ECOX $ECOX 8.1B O/S math: I have 85M (1.05%), DiamondBalls has 299M (3.7%) If 10 whales hold 50 million each that’s 500M (6.2%) 11% of 8.1 billion LOCKED. 🔒 Shares trading are fabricated $AAL $DLAKY $DAL ✈️ $XOM $CVX $VTI 📈 The blockade is about to shatter!

$ECOX No dilution

@OTC_Capitol needs to escape the 12's first. someone keeps dumping into the bid causing this stagnation

If $ecox can blast through these .0013's, a solid move back to new highs is inevitable. The company has so far made all the right moves to position themselves securely and there has been no dilution, just heavy shorting and paper handed day trading

@boudin420 If $ostx doesn't deliver "something" by EOM, its sub $1

$OSTX ww Q1 Data and BLA Submission inbound. OSTX announced that the FDA elevated its Type D Biomarker Meeting to a Type B pre-BLA Meeting for OST-HER2, the company's listeria-based immunotherapy targeting the prevention or delay of recurrent, fully resected, pulmonary metastatic osteosarcoma under the Accelerated Approval Program. The elevation signals a transition from biomarker data review to broader Accelerated Approval discussions, with the meeting expected shortly after OS Therapies completes its clinical data package submission, targeted for the end of Q1 2026. "We credit FDA with taking decisive action to help advance Accelerated Approval discussions regarding OST-HER2 for pediatric cancer patients with osteosarcoma," said Paul Romness, MPH, Chairman and CEO of OS Therapies. "With the biomarker analysis complete, and patent filings in process, we are poised to deliver data to the agency that we believe represents surrogate clinical efficacy sufficient to enable our ongoing BLA submission." OS Therapies holds FDA Orphan Drug, Fast Track, and Rare Pediatric Disease Designations for OST-HER2; if the company receives Accelerated Approval, it becomes eligible for a Priority Review Voucher, which can be sold, and a recent comparable transaction reached $205 million in February 2026.

$belr may jump from .0024 to .0032 in a flash, I'm really enjoying the way this is steadily climbing

$ecox More news and gapping up Shorts are absolutely buried, this could go to .003. - .005 today folks 👀

Never thought I'd see the day $ecox

@mattBrown590276 @Backstabbed14 Not at all grabbed another 15M 6's

I'm going all in this morning at the opening bell on $ecox 6's 7's doesn't matter, this is going penny plus

@StathakisNick This is actually HUGE! All that volume and no dilution means pure market manipulation, naked shorting, off exchange trades and longs loading and holding $ecox

$ECOX. No dilution

$ecox @RHawkBiz is legit I support this company

$ecox This is NOT a sub penny stock or company any more, but will take 10x this volume to move significantly I'm here for glory, this is why I love the OTC

@tharris789 @jtb36 It is back to .0002 x .0003, so his bearish stance is valid. $ecox could have moved on that last PR but they diluted almost 1B shares into the OS...

@jtb36 The definitive merger agreement will be announced soon and then you'll need a new complaint for your bear status

$ECOX this thing is 🐩💩

@Telvantis what a dog turd company $RDAR. Imagine telling investors "soon" and it's been almost 5 months of complete silence.

Anticipation for a PR update with $ecox and the Costa Rica rail project. Feels like we should hear about something soon

$rdar Over 5 months since their last post on X, A bit concerning and I can understand why people are slamming @Telvantis No accountability when a company makes promises and then splits

$rnwf All these updates and still sinking.... Curious 🧐

Where is @Telvantis $rdar

Anyone have theories as to why $ecox had that pop of volume and 911's eod Friday?